Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teduglutide for temporary ileostomy function
NCT03953170Phase 3Withdrawn
- Sponsor
- Allegheny Singer Research Institute
- Start
- Jun 2022
- Primary completion
- Nov 2022
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teduglutide in ileostomy, sponsored by Allegheny Singer Research Institute. Planned start Jun 2022; status: withdrawn.
02
Drugs
teduglutide
03
Conditions
ileostomy
Beyond the preview
Go deeper on NCT03953170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03953170.